OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine
Philipp Zimmer, Andreas Mierau, Wilhelm Bloch, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 2, pp. 347-352
Closed Access | Times Cited: 71
Philipp Zimmer, Andreas Mierau, Wilhelm Bloch, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 2, pp. 347-352
Closed Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
State-dependent alpha peak frequency shifts: Experimental evidence, potential mechanisms and functional implications
Andreas Mierau, Wolfgang Klimesch, Jérémie Lefebvre
Neuroscience (2017) Vol. 360, pp. 146-154
Open Access | Times Cited: 197
Andreas Mierau, Wolfgang Klimesch, Jérémie Lefebvre
Neuroscience (2017) Vol. 360, pp. 146-154
Open Access | Times Cited: 197
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis
Manal T. Usmani, Robert P. Krattli, Sanad M. El-Khatib, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 3, pp. 838-852
Open Access | Times Cited: 22
Manal T. Usmani, Robert P. Krattli, Sanad M. El-Khatib, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 3, pp. 838-852
Open Access | Times Cited: 22
Cancer related cognitive impairment: a downside of cancer treatment
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
AnnaLynn M. Williams, Raven Shah, Michelle Shayne, et al.
Journal of Neuroimmunology (2017) Vol. 314, pp. 17-23
Open Access | Times Cited: 84
AnnaLynn M. Williams, Raven Shah, Michelle Shayne, et al.
Journal of Neuroimmunology (2017) Vol. 314, pp. 17-23
Open Access | Times Cited: 84
What is known and unknown about chemotherapy‐related cognitive impairment in patients with haematological malignancies and areas of needed research
AnnaLynn M. Williams, Clive S. Zent, Michelle C. Janelsins
British Journal of Haematology (2016) Vol. 174, Iss. 6, pp. 835-846
Open Access | Times Cited: 70
AnnaLynn M. Williams, Clive S. Zent, Michelle C. Janelsins
British Journal of Haematology (2016) Vol. 174, Iss. 6, pp. 835-846
Open Access | Times Cited: 70
IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue
J. R. Pereira, Lílian Viana dos Santos, Renata Maria Silva Santos, et al.
Journal of the Neurological Sciences (2016) Vol. 370, pp. 153-156
Closed Access | Times Cited: 69
J. R. Pereira, Lílian Viana dos Santos, Renata Maria Silva Santos, et al.
Journal of the Neurological Sciences (2016) Vol. 370, pp. 153-156
Closed Access | Times Cited: 69
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
Dongdong Shi, Celia M. Dong, Leon C. Ho, et al.
Neurobiology of Disease (2018) Vol. 114, pp. 164-173
Closed Access | Times Cited: 64
Dongdong Shi, Celia M. Dong, Leon C. Ho, et al.
Neurobiology of Disease (2018) Vol. 114, pp. 164-173
Closed Access | Times Cited: 64
B lymphocytes ameliorate Alzheimer’s disease-like neuropathology via interleukin-35
Weixi Feng, Yanli Zhang, Shixin Ding, et al.
Brain Behavior and Immunity (2022) Vol. 108, pp. 16-31
Closed Access | Times Cited: 33
Weixi Feng, Yanli Zhang, Shixin Ding, et al.
Brain Behavior and Immunity (2022) Vol. 108, pp. 16-31
Closed Access | Times Cited: 33
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Cognitive impairment and chemotherapy: a brief overview
Milena Vitali, Carla Ripamonti, Fausto Roila, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 118, pp. 7-14
Closed Access | Times Cited: 60
Milena Vitali, Carla Ripamonti, Fausto Roila, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 118, pp. 7-14
Closed Access | Times Cited: 60
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
Claudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Claudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus
Theresa Currier Thomas, Joshua A. Beitchman, François Pomerleau, et al.
Brain Research (2017) Vol. 1672, pp. 10-17
Open Access | Times Cited: 50
Theresa Currier Thomas, Joshua A. Beitchman, François Pomerleau, et al.
Brain Research (2017) Vol. 1672, pp. 10-17
Open Access | Times Cited: 50
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients
Ding Quan Ng, Ivy Cheng, Claire Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Ding Quan Ng, Ivy Cheng, Claire Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain
Ilhan Lim, Hye-Young Joung, Abigail Yu, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 45
Ilhan Lim, Hye-Young Joung, Abigail Yu, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 45
C-phycocyanin Mitigates Cognitive Impairment in Doxorubicin-Induced Chemobrain: Impact on Neuroinflammation, Oxidative Stress, and Brain Mitochondrial and Synaptic Alterations
Chenying Wang, Yuhang Zhao, Lewei Wang, et al.
Neurochemical Research (2020) Vol. 46, Iss. 2, pp. 149-158
Closed Access | Times Cited: 38
Chenying Wang, Yuhang Zhao, Lewei Wang, et al.
Neurochemical Research (2020) Vol. 46, Iss. 2, pp. 149-158
Closed Access | Times Cited: 38
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy
Michelle C. Janelsins, Mostafa Mohamed, Luke J. Peppone, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 1, pp. 47-59
Open Access | Times Cited: 26
Michelle C. Janelsins, Mostafa Mohamed, Luke J. Peppone, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 114, Iss. 1, pp. 47-59
Open Access | Times Cited: 26
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies
Ding Quan Ng, Daniella Chan, Parisa Agrawal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103748-103748
Open Access | Times Cited: 17
Ding Quan Ng, Daniella Chan, Parisa Agrawal, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103748-103748
Open Access | Times Cited: 17
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal study
Alexandre Chan, Ivy Cheng, Claire Wang, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4821-4831
Open Access | Times Cited: 17
Alexandre Chan, Ivy Cheng, Claire Wang, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4821-4831
Open Access | Times Cited: 17
